About
Technology
Issues
FAQ
Links
Official Page
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.